Related Experiment Video
Updated: Jul 15, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Genetics of osteoporosis
1Molecular Medicine Centre, Rheumatic Diseases Unit, Edinburgh University, Western General Hospital, Edinburgh EH4 2XU, UK. stuart.ralston@ed.ac.uk
Genetic factors significantly influence osteoporosis by affecting bone mineral density (BMD). Understanding these genetic contributions is key to assessing fracture risk and developing new drug treatments for osteoporosis.
Area of Science:
- Genetics
- Bone Biology
- Osteoporosis Research
Background:
- Osteoporosis is a prevalent condition with a substantial genetic influence, characterized by low bone mass and increased fracture risk.
- Genetic factors impact bone mineral density (BMD) and other fracture-related traits, though fracture heritability is moderate.
- While linkage studies have identified quantitative trait loci for BMD, causal genes largely remain unknown.
Purpose of the Study:
- To explore the genetic underpinnings of osteoporosis.
- To identify genetic markers for fracture risk assessment.
- To discover novel molecular targets for osteoporosis drug development.
Main Methods:
- Review of twin and family studies on osteoporosis heritability.
- Analysis of linkage studies in monogenic bone diseases and population-based studies.
- Investigation of candidate gene polymorphisms and their association with bone mass and fracture.
Main Results:
- Genetic factors play a significant role in regulating BMD.
- Polymorphisms in candidate genes are associated with bone mass and osteoporotic fracture, but individually explain a small genetic contribution.
- Environmental factors and their interaction with genetic polymorphisms also influence BMD.
Conclusions:
- Advances in understanding osteoporosis genetics are crucial for elucidating disease pathophysiology.
- Genetic insights can provide new markers for fracture risk assessment.
- Identifying specific genes and pathways will guide the development of next-generation osteoporosis therapies.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Bone Remodeling
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...